An uncommon case of epidermolysis bullosa acquisita associated with systemic sclerosis
Ann Dermatol Venereol. 2023 Aug 16:S0151-9638(23)00064-9. doi: 10.1016/j.annder.2023.06.003. Online ahead of print.NO ABSTRACTPMID:37596129 | DOI:10.1016/j.annder.2023.06.003 (Source: Annales de Dermatologie et de Cenereologie)
Source: Annales de Dermatologie et de Cenereologie - August 18, 2023 Category: Dermatology Authors: C Labonne D Boutin S Baali P Roblot E Frouin O Renaud E Hainaut M Masson Regnault Source Type: research

Treatment of pediatric ocular rosacea: A systematic review
CONCLUSION: Systemic antibiotics, led by doxycycline, were the most commonly reported treatment modalities for pediatric ocular rosacea. Increased awareness of ocular rosacea in this population is crucial for earlier diagnosis.PMID:37596128 | DOI:10.1016/j.annder.2023.05.004 (Source: Annales de Dermatologie et de Cenereologie)
Source: Annales de Dermatologie et de Cenereologie - August 18, 2023 Category: Dermatology Authors: S Khaslavsky S Y Starkey S Avraham N Kashetsky I Mukovozov Source Type: research

An uncommon case of epidermolysis bullosa acquisita associated with systemic sclerosis
Ann Dermatol Venereol. 2023 Aug 16:S0151-9638(23)00064-9. doi: 10.1016/j.annder.2023.06.003. Online ahead of print.NO ABSTRACTPMID:37596129 | DOI:10.1016/j.annder.2023.06.003 (Source: Annales de Dermatologie et de Cenereologie)
Source: Annales de Dermatologie et de Cenereologie - August 18, 2023 Category: Dermatology Authors: C Labonne D Boutin S Baali P Roblot E Frouin O Renaud E Hainaut M Masson Regnault Source Type: research

Dermatologic toxicities to inhibitors of cyclin-dependent kinases CDK 4 and 6: An updated review for clinical practice
Ann Dermatol Venereol. 2023 Aug 14:S0151-9638(23)00047-9. doi: 10.1016/j.annder.2022.11.013. Online ahead of print.ABSTRACTCyclin-dependent kinase (CDK) 4/6 inhibitors (palbociclib, ribociclib and abemaciclib) have revolutionized the treatment of metastatic breast carcinoma. They currently form the first-line treatment, in combination with endocrine agents, for the management of locally advanced or metastatic hormone receptor-positive (HR + ), human epidermal growth factor receptor 2-negative (HER2-) breast cancer, the largest subtype of breast carcinoma. CDK 4/6 inhibitors have shown comparable efficacy outcomes with pred...
Source: Annales de Dermatologie et de Cenereologie - August 16, 2023 Category: Dermatology Authors: V Sibaud P Sollena Source Type: research

Allergy activity in the dermatology department of a French university hospital over a 2-year period: A retrospective study of 1813 patients
Ann Dermatol Venereol. 2023 Aug 14:S0151-9638(23)00062-5. doi: 10.1016/j.annder.2023.06.001. Online ahead of print.NO ABSTRACTPMID:37586899 | DOI:10.1016/j.annder.2023.06.001 (Source: Annales de Dermatologie et de Cenereologie)
Source: Annales de Dermatologie et de Cenereologie - August 16, 2023 Category: Dermatology Authors: L Gosse B Sterling V Liabeuf M-P Lehucher C Gaudy M-A Richard Source Type: research

Dermatologic toxicities to inhibitors of cyclin-dependent kinases CDK 4 and 6: An updated review for clinical practice
Ann Dermatol Venereol. 2023 Aug 14:S0151-9638(23)00047-9. doi: 10.1016/j.annder.2022.11.013. Online ahead of print.ABSTRACTCyclin-dependent kinase (CDK) 4/6 inhibitors (palbociclib, ribociclib and abemaciclib) have revolutionized the treatment of metastatic breast carcinoma. They currently form the first-line treatment, in combination with endocrine agents, for the management of locally advanced or metastatic hormone receptor-positive (HR + ), human epidermal growth factor receptor 2-negative (HER2-) breast cancer, the largest subtype of breast carcinoma. CDK 4/6 inhibitors have shown comparable efficacy outcomes with pred...
Source: Annales de Dermatologie et de Cenereologie - August 16, 2023 Category: Dermatology Authors: V Sibaud P Sollena Source Type: research

Allergy activity in the dermatology department of a French university hospital over a 2-year period: A retrospective study of 1813 patients
Ann Dermatol Venereol. 2023 Aug 14:S0151-9638(23)00062-5. doi: 10.1016/j.annder.2023.06.001. Online ahead of print.NO ABSTRACTPMID:37586899 | DOI:10.1016/j.annder.2023.06.001 (Source: Annales de Dermatologie et de Cenereologie)
Source: Annales de Dermatologie et de Cenereologie - August 16, 2023 Category: Dermatology Authors: L Gosse B Sterling V Liabeuf M-P Lehucher C Gaudy M-A Richard Source Type: research

Dermatologic toxicities to inhibitors of cyclin-dependent kinases CDK 4 and 6: An updated review for clinical practice
Ann Dermatol Venereol. 2023 Aug 14:S0151-9638(23)00047-9. doi: 10.1016/j.annder.2022.11.013. Online ahead of print.ABSTRACTCyclin-dependent kinase (CDK) 4/6 inhibitors (palbociclib, ribociclib and abemaciclib) have revolutionized the treatment of metastatic breast carcinoma. They currently form the first-line treatment, in combination with endocrine agents, for the management of locally advanced or metastatic hormone receptor-positive (HR + ), human epidermal growth factor receptor 2-negative (HER2-) breast cancer, the largest subtype of breast carcinoma. CDK 4/6 inhibitors have shown comparable efficacy outcomes with pred...
Source: Annales de Dermatologie et de Cenereologie - August 16, 2023 Category: Dermatology Authors: V Sibaud P Sollena Source Type: research

Allergy activity in the dermatology department of a French university hospital over a 2-year period: A retrospective study of 1813 patients
Ann Dermatol Venereol. 2023 Aug 14:S0151-9638(23)00062-5. doi: 10.1016/j.annder.2023.06.001. Online ahead of print.NO ABSTRACTPMID:37586899 | DOI:10.1016/j.annder.2023.06.001 (Source: Annales de Dermatologie et de Cenereologie)
Source: Annales de Dermatologie et de Cenereologie - August 16, 2023 Category: Dermatology Authors: L Gosse B Sterling V Liabeuf M-P Lehucher C Gaudy M-A Richard Source Type: research

Subcutaneous panniculitis-like T-cell lymphoma presenting as facial infiltration with long-term response to methotrexate: Two cases
Ann Dermatol Venereol. 2023 Jul 12:S0151-9638(23)00061-3. doi: 10.1016/j.annder.2023.04.003. Online ahead of print.NO ABSTRACTPMID:37442745 | DOI:10.1016/j.annder.2023.04.003 (Source: Annales de Dermatologie et de Cenereologie)
Source: Annales de Dermatologie et de Cenereologie - July 13, 2023 Category: Dermatology Authors: D Marc é D Canu C Laurent C Pottier M-L Jullie T Kervarrec M Beylot-Barry M Samimi Source Type: research

Subcutaneous panniculitis-like T-cell lymphoma presenting as facial infiltration with long-term response to methotrexate: Two cases
Ann Dermatol Venereol. 2023 Jul 12:S0151-9638(23)00061-3. doi: 10.1016/j.annder.2023.04.003. Online ahead of print.NO ABSTRACTPMID:37442745 | DOI:10.1016/j.annder.2023.04.003 (Source: Annales de Dermatologie et de Cenereologie)
Source: Annales de Dermatologie et de Cenereologie - July 13, 2023 Category: Dermatology Authors: D Marc é D Canu C Laurent C Pottier M-L Jullie T Kervarrec M Beylot-Barry M Samimi Source Type: research

Subcutaneous panniculitis-like T-cell lymphoma presenting as facial infiltration with long-term response to methotrexate: Two cases
Ann Dermatol Venereol. 2023 Jul 12:S0151-9638(23)00061-3. doi: 10.1016/j.annder.2023.04.003. Online ahead of print.NO ABSTRACTPMID:37442745 | DOI:10.1016/j.annder.2023.04.003 (Source: Annales de Dermatologie et de Cenereologie)
Source: Annales de Dermatologie et de Cenereologie - July 13, 2023 Category: Dermatology Authors: D Marc é D Canu C Laurent C Pottier M-L Jullie T Kervarrec M Beylot-Barry M Samimi Source Type: research

Subcutaneous panniculitis-like T-cell lymphoma presenting as facial infiltration with long-term response to methotrexate: Two cases
Ann Dermatol Venereol. 2023 Jul 12:S0151-9638(23)00061-3. doi: 10.1016/j.annder.2023.04.003. Online ahead of print.NO ABSTRACTPMID:37442745 | DOI:10.1016/j.annder.2023.04.003 (Source: Annales de Dermatologie et de Cenereologie)
Source: Annales de Dermatologie et de Cenereologie - July 13, 2023 Category: Dermatology Authors: D Marc é D Canu C Laurent C Pottier M-L Jullie T Kervarrec M Beylot-Barry M Samimi Source Type: research

Subcutaneous panniculitis-like T-cell lymphoma presenting as facial infiltration with long-term response to methotrexate: Two cases
Ann Dermatol Venereol. 2023 Jul 12:S0151-9638(23)00061-3. doi: 10.1016/j.annder.2023.04.003. Online ahead of print.NO ABSTRACTPMID:37442745 | DOI:10.1016/j.annder.2023.04.003 (Source: Annales de Dermatologie et de Cenereologie)
Source: Annales de Dermatologie et de Cenereologie - July 13, 2023 Category: Dermatology Authors: D Marc é D Canu C Laurent C Pottier M-L Jullie T Kervarrec M Beylot-Barry M Samimi Source Type: research

Subcutaneous panniculitis-like T-cell lymphoma presenting as facial infiltration with long-term response to methotrexate: Two cases
Ann Dermatol Venereol. 2023 Jul 12:S0151-9638(23)00061-3. doi: 10.1016/j.annder.2023.04.003. Online ahead of print.NO ABSTRACTPMID:37442745 | DOI:10.1016/j.annder.2023.04.003 (Source: Annales de Dermatologie et de Cenereologie)
Source: Annales de Dermatologie et de Cenereologie - July 13, 2023 Category: Dermatology Authors: D Marc é D Canu C Laurent C Pottier M-L Jullie T Kervarrec M Beylot-Barry M Samimi Source Type: research